Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eastwood Bio-Medical Canada Inc (TSE:EBM)
:EBM
EBM Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.25 - C$1.15
Previous CloseN/A
Volume2.20K
Average Volume (3M)1.50K
Market Cap
C$29.62M
Enterprise ValueC$23.09M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Mar 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding68,885,970
10 Day Avg. Volume1,708
30 Day Avg. Volume1,499
Standard Deviation0.22
R-Squared0.00003
Alpha-0.00300
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)45.32
Price to Cash Flow (P/CF)-421.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Options Prices
Currently, No data available
---
Ownership Overview
EBM FAQ
What was Eastwood Bio-Medical Canada Inc’s price range in the past 12 months?
Eastwood Bio-Medical Canada Inc lowest stock price was C$0.25 and its highest was C$1.15 in the past 12 months.
What is Eastwood Bio-Medical Canada Inc’s market cap?
Eastwood Bio-Medical Canada Inc’s market cap is C$29.62M.
When is Eastwood Bio-Medical Canada Inc’s upcoming earnings report date?
Eastwood Bio-Medical Canada Inc’s upcoming earnings report date is Mar 28, 2025 which is in 37 days.
How were Eastwood Bio-Medical Canada Inc’s earnings last quarter?
Eastwood Bio-Medical Canada Inc released its earnings results on Sep 26, 2024. The company reported -C$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.002.
Is Eastwood Bio-Medical Canada Inc overvalued?
According to Wall Street analysts Eastwood Bio-Medical Canada Inc’s price is currently Overvalued.
Does Eastwood Bio-Medical Canada Inc pay dividends?
Eastwood Bio-Medical Canada Inc does not currently pay dividends.
What is Eastwood Bio-Medical Canada Inc’s EPS estimate?
Eastwood Bio-Medical Canada Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eastwood Bio-Medical Canada Inc have?
Eastwood Bio-Medical Canada Inc has 68,885,970 shares outstanding.
What happened to Eastwood Bio-Medical Canada Inc’s price movement after its last earnings report?
Eastwood Bio-Medical Canada Inc reported an EPS of -C$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Eastwood Bio-Medical Canada Inc?
Currently, no hedge funds are holding shares in TSE:EBM
---
Company Description
Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc is engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus (NIDDM-Type II diabetes). The company's Eleotin brand of products provide natural sourced solutions for metabolic syndromes such as blood glucose control, obesity, and hypertension. Eleotin was initially developed by the scientists at the Julia McFarlane Diabetes Research Center (JMDRC) at the University of Calgary in Alberta, Canada. After the initial development by the JMDRC, research and development were continued by Eastwood Bio-Medical Research Inc., the Company, and other institutions around the world, including Tsinghua University of the People's Republic of China.
---
Technical Analysis
POET Technologies
―
Biome Grow Inc
―
Gold State Resources Inc.
―
Premier Health of America Inc
―
---